PHARMA EVIDENCE ApS: Financial statements 2013
CVR: 34586519
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
PHARMA EVIDENCE ApS (CVR 34586519) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 891,935 and a net result of DKK 54,150 compared with DKK -447,585 the year before. That is an increase of 2.7% compared with the year before. Equity in the 2013 report amounted to DKK 464,123. The solvency ratio was 75.8%.
- Gross Profit
- DKK 891,935
- Profit/Loss
- DKK 54,150
- Equity
- DKK 464,123
- Total Assets
- DKK 611,960
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | - | 892 t. | 54 t. | 464 t. | - |
| 2012 | - | 868 t. | -448 t. | 410 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
PHARMA EVIDENCE ApS has published its annual report for 2012. Gross profit came to DKK 868,148, and the net result was DKK -447,585.
About PHARMA EVIDENCE ApS
PHARMA EVIDENCE ApS is a Danish company of the type Anpartsselskab based in Farum, founded in 2012. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Tove Holm-Larsen. The company is owned by HB World Holding ApS. The company has 1 employee (2023). In 2025, the company reported a gross profit of DKK 64,007 and a net result of DKK 62,147 compared with DKK -179,749 the year before. Equity in the 2025 report amounted to DKK 134,401.